期刊文献+

重视慢性丙型肝炎合并其他系统疾病的诊治 被引量:2

Emphasis on diagnosis and treatment of chronic hepatitis C complicated with diseases of other systems
原文传递
导出
摘要 丙型肝炎病毒(hepatitis C virus,HCV)除感染肝脏外,还可以侵犯淋巴系统、肾脏、骨髓、甲状腺等多个组织和器官。因此,慢性丙型肝炎(chronic hepatitis C,CHC)患者在临床除了出现肝脏受损的表现外,还可以出现多器官受累的临床表现,如合并糖尿病、肾病、自身免疫性疾病、血液系统疾病等,使CHC的治疗变得比较复杂,特别是使用干扰素进行抗病毒治疗时,既要考虑药物的有效性,又要避免对其他伴随疾病的影响。本期笔谈结合最近的临床研究,对CHC患者合并上述其他内科疾病的临床特点、疾病间的相互影响以及治疗策略进行专题讨论,其目的是为了指导临床医生更好地认识和治疗CHC合并其他疾病的患者。 Hepatitis C virus(HCV) can be replicated in extra-hepatic cells, including lymph nodes, kidney, bone marrow and thyroid. HCV infection is associated with several extra-hepatic manifestations, as mixed cryoglobulinemia, lymphomas, rheumatic disorders, autoimmune thyroiditis, hypothyroidism, and type 2 diabetes. Successful eradication of HCV with interferon alfa and ribavirin was shown to improve some of these extra-hepatic effects and sustained virological response is associated with resolution of those complications. This chapter we will focus on the HCV infection and extra-hepatic manifestations in clinical features, interaction and treatment strategy.
作者 窦晓光 白菡
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2016年第3期173-175,共3页 Chinese Journal of Practical Internal Medicine
关键词 慢性丙型肝炎 丙型肝炎病毒 糖尿病 自身免疫性疾病 chronic hepatitis C hepatitis C virus diabetes autoimmune disease
  • 相关文献

参考文献1

二级参考文献20

  • 1M.Recasens,E.Aguilera,S.Ampurdanés,J. M.Sánchez Tapias,O.Simó,R.Casamitjana,I.Conget.Abrupt onset of diabetes during interferon‐alpha therapy in patients with chronic hepatitis C[J]. Diabetic Medicine . 2008 (9)
  • 2Manfred Wiese,Kurt Grüngreiff,Wolfgang Güthoff,Michael Lafrenz,Ute Oesen,Heiner Porst.Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany—a 25-year multicenter study[J].Journal of Hepatology.2005(4)
  • 3Mehta S H,Brancati F L,Sulkowski M S,Strathdee S A,Szklo M,Thomas D L.Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Annals of Internal Medicine . 2000
  • 4Karvonen M,Viik-Kajander M,Moltchanova E,Libman I,LaPorte R,Tuomilehto J.Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care . 2000
  • 5Mohammed Eyad Yaseen Alsabbagh,Naseem Eisa,Abdul Hamid Alraiyes,M Chadi Alraies.Chronic hepatitis C therapy: a rare complication revisited[J]. Case Reports . 2013 (jul2)
  • 6Hiroaki Yagyu,Kenta Okada,Shin Sato,Yumiko Yamashita,Nobukazu Okada,Jun-ichi Osuga,Shoichiro Nagasaka,Kentaro Sugano,Shun Ishibashi.Pegylated interferon-α2b and ribavirin combination therapy induces Hashitoxicosis followed by type 1 diabetes mellitus[J]. Diabetes Research and Clinical Practice . 2011 (3)
  • 7G. Scavone,F. Zaccardi,A. Manto,S. Caputo,D. Pitocco,G. Ghirlanda.A case of chronic hepatitis C developing insulin-dependent diabetes, thyroid autoimmunity and stiff-person syndrome as complications of interferon therapy[J]. Diabetes Research and Clinical Practice . 2010 (2)
  • 8Masayuki Hayashi,Yuko Kataoka,Kazushige Tachikawa,Hiroki Koguchi,Hiroshi Tanaka.Dual onset of type 1 diabetes mellitus and Graves’ disease during treatment with pegylated interferon α-2b and ribavirin for chronic hepatitis C[J]. Diabetes Research and Clinical Practice . 2009 (2)
  • 9G. Tosone,G. Borgia,I. Gentile,R. Cerini,M. C. D. Conte,R. Orlando,M. Piazza.A case of pegylated interferon alpha-related diabetic ketoacidosis: can this complication be avoided?[J]. Acta Diabetologica . 2007 (3)
  • 10Raffaele Cozzolongo,Corrado Betterle,Paolo Fabris,Maria Paola Albergoni,Elsa Lanzilotta,Onofrio G. Manghisi.Onset of type 1 diabetes mellitus during peginterferon α-2b plus ribavirin treatment for chronic hepatitis C[J]. European Journal of Gastroenterology & Hepatology . 2006 (6)

共引文献17

同被引文献22

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部